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Introduction
Juvenile Systemic Lupus Erythematous (JSLE) is charac-
terised by auto-antibody production directed against
nuclear auto-antigens. Toll-like receptors (TLRs) are pat-
tern recognition receptors of the innate immune system
responsible for initiating an immune response against
invading pathogens. TLR 3, 7-9 have been studied in SLE
due to their unique ability to detect nuclear antigen. Their
expression is increased in JSLE and significantly associated
with disease activity and anti-dsDNA titres. Upon recogni-
tion of an extracellular pathogen, neutrophils may release
neutrophil extracellular traps (NETs) containing antimi-
crobial peptides to capture and neutralise pathogens.
Nuclear material including DNA and histones comprise
the major structural components of NETs and may act as
a source of nuclear auto-antigen in SLE. The mechanism
by which NETs may induce an auto-inflammatory
response has not been elucidated. Our hypothesis is that
neutrophil NETs are a source of nuclear auto-antigen in
JSLE being detected through the TLR pathway leading to
an auto-inflammatory response.
Objectives
To investigate whether NETs are able to activate the TLR
pathway, using pIRAK1, a signalling protein specific to the
TLR pathway
Methods
Neutrophils were isolated from children with JSLE and
paediatric & adult non-inflammatory controls and were
either left unstimulated or incubated with 100ng IFN-
alpha for 2 hours. Induction of NETs was visualised
using confocal microscopy. Extracellular DNA was mea-
sured using the Quant-iT Picogreen assay (Invitrogen,
Carlsbad, CA).
PBMCs were isolated from healthy adult controls and
either left unstimulated or induced with LPS, TLR7/
TLR9 agonist, as a positive control, or NETs derived
from JSLE, paediatric or adult control neutrophils with
+/- IFN-a for 30 minutes; cell protein was then
extracted. pIRAK1 protein expression was determined
by Western blot and normalised to b-actin expression.
Results
Cells incubated with LPS (×1.4 fold), TLR 7 (×1.7) & 9
(×1.7) agonists and NETs showed increased pIRAK
protein expression as compared to unstimulated
PBMCs. PBMCs incubated with NETs containing higher
concentrations of dsDNA showed a greater fold increase
in pIRAK1 protein expression. Increased expression did
not seem to be influenced by origin of NET.
Conclusion
Neutrophil NETosis has been proposed as a potential
mechanism for auto-antigen exposure in SLE and has
been shown to be dysregulated in lupus and correlate with
lupus nephritis. Here we have shown that NETs are
capable of activating the TLR 7/9 pathway and suggest
that this is one mechanism by which an autoimmune
response is driven. We have shown this to occur in a dose
dependent manner to dsDNA. This data adds to the
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